Seven Fleet Capital Management LP
Long book
$318.3M
Q1 2026
Positions
115
Top-10 weight
51%
concentration
Last quarter
+15.6%
SPY +14.8%
Turnover
61%
of book per quarter
Strategy in plain words
auto-generated from filingsSeven Fleet Capital Management LP is a quantitative fund whose holdings reflect models, not opinions, specialised in healthcare (99% of the long book), running a $318.3M US long book across 115 positions.
The portfolio is concentrated: the top 10 names carry 51% of the portfolio. Turnover is high — positions rotate quickly, so individual names matter less than the process. Current anchor positions: CG ONCOLOGY INC, TANGO THERAPEUTICS INC, REVOLUTION MEDICINES INC, TYRA BIOSCIENCES INC, LIQUIDIA CORP.
Signal value of individual moves is limited — treat changes as weak evidence.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q4 2025
+36.0%
Q1 2026
+15.6%
Sector allocation
Healthcare 97%
Other 2%
Materials 1%
Long book by quarter
What does Seven Fleet own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| CGON CG ONCOLOGY INC | Healthcare | 1.4M | $97.4M | 30.6% | New |
| TNGX TANGO THERAPEUTICS INC | Healthcare | 502.0K | $10.5M | 3.3% | +133.3% |
| RVMD REVOLUTION MEDICINES INC | Healthcare | 80.8K | $7.9M | 2.5% | +22.8% |
| TYRA TYRA BIOSCIENCES INC | Healthcare | 195.7K | $7.5M | 2.4% | +146.0% |
| LQDA LIQUIDIA CORP | Healthcare | 187.9K | $7.1M | 2.2% | +105.9% |
| AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 209.5K | $7.1M | 2.2% | +560.2% |
| IPSC CENTURY THERAPEUTICS INC | Healthcare | 2.9M | $6.7M | 2.1% | New |
| ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 164.0K | $6.4M | 2.0% | +64.1% |
| PCVX VAXCYTE INC | Healthcare | 108.5K | $6.3M | 2.0% | +327.6% |
| TNGX TANGO THERAPEUTICS INC | Healthcare | 300.6K | $6.3M | 2.0% | New |
| COGT COGENT BIOSCIENCES INC | Healthcare | 149.4K | $5.8M | 1.8% | -30.2% |
| AVTX AVALO THERAPEUTICS INC | Healthcare | 360.1K | $5.4M | 1.7% | New |
| NERV MINERVA NEUROSCIENCES INC | Healthcare | 889.3K | $5.4M | 1.7% | New |
| CGON CG ONCOLOGY INC | Healthcare | 75.8K | $5.1M | 1.6% | -95.0% |
| PHVS PHARVARIS NV | Healthcare | 172.7K | $4.9M | 1.5% | +212.1% |
| DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 54.3K | $4.6M | 1.4% | +270.3% |
| CYTK CYTOKINETICS INC | Healthcare | 61.3K | $4.0M | 1.3% | +492.8% |
| SLNOEUR SOLENO THERAPEUTICS INC | — | 115.8K | $3.9M | 1.2% | -11.0% |
| ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 95.3K | $3.7M | 1.2% | New |
| ERAS ERASCA INC | Healthcare | 222.5K | $3.6M | 1.1% | New |
| ROIV ROIVANT SCIENCES LTD | Healthcare | 128.2K | $3.6M | 1.1% | New |
| CTMX CYTOMX THERAPEUTICS INC. | Healthcare | 714.0K | $3.4M | 1.1% | New |
| AVTX AVALO THERAPEUTICS INC | Healthcare | 213.8K | $3.2M | 1.0% | +237.6% |
| IPSC CENTURY THERAPEUTICS INC | Healthcare | 1.4M | $3.2M | 1.0% | New |
| EPRX EUPRAXIA PHARMACEUTICALS INC | Healthcare | 433.5K | $3.1M | 1.0% | New |
| IDYA IDEAYA BIOSCIENCES INC | Healthcare | 86.3K | $2.9M | 0.9% | New |
| TSHA TAYSHA GENE THERAPIES INC | Healthcare | 625.7K | $2.8M | 0.9% | +274.2% |
| CMPX COMPASS THERAPEUTICS INC | Healthcare | 517.0K | $2.7M | 0.9% | -9.1% |
| DMRA DAMORA THERAPEUTICS INC | Healthcare | 101.2K | $2.6M | 0.8% | New |
| 4XC1 KALVISTA PHARMACEUTICALS INC | — | 128.5K | $2.6M | 0.8% | +165.4% |
| RLAY RELAY THERAPEUTICS INC | Healthcare | 257.7K | $2.6M | 0.8% | +253.1% |
| AXSM AXSOME THERAPEUTICS INC | Healthcare | 14.1K | $2.4M | 0.7% | +8.5% |
| CMPX COMPASS THERAPEUTICS INC | Healthcare | 423.6K | $2.2M | 0.7% | New |
| EPRX EUPRAXIA PHARMACEUTICALS INC | Healthcare | 276.0K | $2.0M | 0.6% | New |
| DFTX DEFINIUM THERAPEUTICS INC | Materials | 99.9K | $1.9M | 0.6% | New |
| MLYS MINERALYS THERAPEUTICS INC | Healthcare | 69.6K | $1.9M | 0.6% | +65.5% |
| MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 3.4K | $1.8M | 0.6% | +82.4% |
| CTMX CYTOMX THERAPEUTICS INC | Healthcare | 371.4K | $1.7M | 0.5% | +659.5% |
| LONA LEONABIO INC | Healthcare | 164.7K | $1.7M | 0.5% | +28.7% |
| SVRA SAVARA INC | Healthcare | 295.7K | $1.6M | 0.5% | +371.1% |
| CATX PERSPECTIVE THERAPEUTICS INC | Healthcare | 379.1K | $1.6M | 0.5% | New |
| ASMB ASSEMBLY BIOSCIENCES INC | Healthcare | 56.1K | $1.6M | 0.5% | -23.9% |
| SABS SAB BIOTHERAPEUTICS INC | Healthcare | 400.0K | $1.5M | 0.5% | New |
| NERV MINERVA NEUROSCIENCES INC | Healthcare | 248.5K | $1.5M | 0.5% | New |
| TARS TARSUS PHARMACEUTICALS INC | Healthcare | 19.8K | $1.4M | 0.4% | +340.0% |
| CRVS CORVUS PHARMACEUTICALS INC | Healthcare | 82.9K | $1.2M | 0.4% | New |
| PCVX VAXCYTE INC | Healthcare | 20.0K | $1.2M | 0.4% | New |
| AVBP ARRIVENT BIOPHARMA INC | Healthcare | 50.3K | $1.2M | 0.4% | New |
| LRMR LARIMAR THERAPEUTICS INC | Healthcare | 256.6K | $1.2M | 0.4% | New |
| KRYS KRYSTAL BIOTECH INC | Healthcare | 4.3K | $1.1M | 0.4% | +7.9% |